Sophie E. Claudel, MD

Clinical Instructor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Sophie Claudel is a Nephrology Fellow and early-career investigator at Boston Medical Center and the Boston University Chobanian & Avedisian School of Medicine. She earned her MD from the Wake Forest University School of Medicine and completed a clinical research fellowship at the National Institutes of Health. She completed her Internal Medicine residency and chief residency at Boston Medical Center through the NIH R38-funded Promoting Research in Medical Residency (PRIMER) pathway.

Dr. Claudel’s research examines the bidirectional relationship between chronic kidney disease and cardiovascular disease. By integrating epidemiology, clinical phenotyping, and physiologic studies, she aims to uncover shared mechanisms of disease and inform strategies for prevention. She is also a member of the CURE Consortium, a multinational research group investigating chronic kidney disease of unknown etiology (CKDu) in Central America and India focusing on identifying causal exposures and novel kidney biomarkers.

Publications

  • Published 7/29/2025

    Wittig M, Verma A, Bellavia A, Rosan S, Claudel SE, Surapaneni A, Palsson R, Srivastava A, Stillman IE, Henderson JM, Beck LH, Hodgin JB, Grams ME, Rhee EP, Huber TB, Waikar SS, Schmidt IM. The Associations of Foot Process Effacement with Kidney Histopathologic Lesions and Disease Progression. Kidney360. 2025 Jul 29. PMID: 40728890.

    Read at: PubMed

  • Published 5/2/2025

    Claudel SE, Waikar SS, Verma A. Albuminuria References Ranges in Healthy US Adults. J Appl Lab Med. 2025 May 02; 10(3):767-771. PMID: 39981782.

    Read at: PubMed

  • Published 4/14/2025

    Solomon M, Claudel S, Verma A. Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations. Cardiol Clin. 2025 Aug; 43(3):337-357. PMID: 40582729.

    Read at: PubMed

  • Published 4/1/2025

    Claudel SE, Schmidt IM, Waikar SS, Verma A. Albuminuria: A Marker of Adverse Kidney Outcomes in Heart Failure. J Am Coll Cardiol. 2025 Apr 01; 85(12):1372-1375. PMID: 40139894.

    Read at: PubMed

  • Published 3/17/2025

    Schmidt IM, Verma A, Claudel SE, Palsson R, Srivastava A, Stillman IE, Beck LH, Waikar SS. Genetic Testing in Biopsy-Confirmed Kidney Disease. Kidney Med. 2025 May; 7(5):100994. PMID: 40321977.

    Read at: PubMed

Other Positions

  • Resident Physician, Nephrology
    Boston Medical Center